EBIT at other companies
Other financials
Where this comes from
Calculated from Charles River Laboratories’s reported figures.
Plus components not separately reported this period.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's EBIT?
- Charles River Laboratories (CRL) reported EBIT of $119.9M in Q1 2026.
- How has Charles River Laboratories's EBIT changed year-over-year?
- Charles River Laboratories's EBIT increased by 60.6% year-over-year, from $74.67M to $119.9M.
- What is the long-term trend for Charles River Laboratories's EBIT?
- Over 4 years (2021 to 2025), Charles River Laboratories's EBIT has grown at a -15.0% compound annual growth rate (CAGR), from $589.86M to $307.5M.
- What does EBIT mean?
- Profit before interest and taxes — the business's core earning power.
- How do you interpret EBIT?
- Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
- How does EBIT compare across companies?
- Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.